AF Medication Selection and Disparities

CE / CME

Atrial Fibrillation Case Considerations: Medication Selection in the Face of Health Disparities

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: January 05, 2024

Expiration: January 04, 2025

David S. Kountz
David S. Kountz, MD, MBA, MACP

Activity

Progress
1 2
Course Completed

Presurvey

A 68-year-old female with a past medical history of hypertension and chronic kidney disease is diagnosed with atrial fibrillation (AF). You calculate her CHA2DS2-VASc score to be 3 (1 point for age, 1 point for female, 1 point for hypertension) and decide to initiate anticoagulation. Her baseline serum creatinine (SCr) is 1.6 mg/dL, she weighs 58 kg, and she has an estimated creatinine clearance (CrCl) of 31 mL/min. Which of the following anticoagulation regimens would be most appropriate for this patient?

Which of the following methods can best overcome financial barriers to anticoagulation therapy for individuals facing financial hardship?